iSpecimen Inc.ISPCNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank17
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P17
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -1.03% |
| 2023 | 34.28% |
| 2022 | 44.53% |
| 2021 | 25.42% |
| 2020 | 47.52% |
| 2019 | -17.91% |
| 2018 | 0.00% |